## Abstract To evaluate the fraction of invasive cervical carcinoma (ICC) that could be prevented in HIVβinfected women by vaccines currently available against human papillomavirus (HPV)16 and 18, we conducted a crossβsectional study in women with ICC in Nairobi, Kenya. Fiftyβone HIVβpositive women
HPV types present in invasive cervical cancers of HIV-seropositive women
β Scribed by Howard D. Strickler; Joel M. Palefsky; Robert D. Burk
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- French
- Weight
- 43 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been reported that cervical intraepithelial lesions have a more aggressive course in HIV-seropositive than in HIV-seronegative women. In the present investigation, the progression of these cervical lesions was studied in a group of HIV-seropositive women. Of 1,587 patients, 200 (12.6%) had a
Cervical cancer is the second most common cancer among Tunisian women, and the incidence rates vary by region. Three Tunisian registries report age-standardized rates of 6.3/ 10 5 in the central region, 5.4/10 5 in the north, and 2.7/10 5 in the south. High-risk human papillomavirus (HPV) types and
## Abstract Although the relation between cervical cancer and the human papillomavirus (HPV) has been established beyond doubt, the introduction of HPV detection in cervical cancer screening is halted, primarily by the high rate of false positivity in relation to morbidity, since the majority of wo
Within the context of a larger hospital-based case-control ment of subjects lasted from September 1,1983 through March study carried out to assess the efficacy of cervical cancer 31. 1985. screening, the possible association between oral contracep-+he series comprises 129 with newly diagnosed tives